(NASDAQ: PEPG) Pepgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Pepgen's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PEPG's revenue for 2025 to be $646,442,810, with the lowest PEPG revenue forecast at $646,442,810, and the highest PEPG revenue forecast at $646,442,810. On average, 1 Wall Street analysts forecast PEPG's revenue for 2026 to be $2,423,998,765, with the lowest PEPG revenue forecast at $2,423,998,765, and the highest PEPG revenue forecast at $2,423,998,765.
In 2027, PEPG is forecast to generate $2,206,900,104 in revenue, with the lowest revenue forecast at $984,223,738 and the highest revenue forecast at $3,429,576,470.